Summary
Serum kinetics of Doxycycline polyphosphate (DPP) have been studied in dogs after oral administration of 10 mg.kg−1 by measurement of total serum concentration (Ct) of tetracycline derivatives by a chemical assay and active concentration (Ca) by a microbiological method.
Kinetics have been studied using a one compartment open model with absorption by oral route.
DPP is rapidly absorbed, the peak serum level is reached three hours after absorption and slowly eliminated (elimination half-life =12 hours).
The main differences observed between Ct and Ca kinetics are in the values of the areas under the curves (AUC) and the peak serum level. The values obtained for these parameters for Ca kinetics were found to be 50% of those obtained for Ct, the volumes of distribution being in inverse proportion.
These results are in a good agreement with the correlation and linear regression observed between Ca and Ct showing that 55% of total serum Doxycycline possesses immediate antibacterial activity. It is postulated that this difference between Ct and Ca kinetics is essentially a reflection of the ratios of bound and free drug.
Similar results were obtained with the finished pharmaceutical form except for a 15% increase of AUC indicating improvement of the bioavailability of the drug.
Similar content being viewed by others
References
Neuvonen P.J. (1976): Drugs, Interactions with the absorption of tetracyclines,11, 45–54.
Forsgren A. and Gnarpe H. (1973): Antimicrob. Agents and Chemother., Tetracyclines and host-defense mechanisms,3, 6, 711–715.
Forsgren A. and Gnarpe H. (1973): Nature New Biology, Tetracycline interference with the bactericidal effect of serum,244, 133, 82–83.
Arcilla J.D., Fiore J.L., Resnick O., Nadelmann J.W., Huth J.L. and Troetel W.M. (1974): Curr. Ther. Res., Comparative bioavailability of doxycycline,16, 10, 1126–1136.
Welling P.G., Koch P.A., Lau C.C. and Craig W.A. (1977): Antimicrobial Agents Chemother., Bioavailability of tetracycline and doxycycline in fasted and nonfasted subjects,11, 462–469.
Kohn K.W. (1961): Anal. Chem., Determination of tetracyclines by extraction of fluorescent complexes — Application to biological materials,33, 7, 862–866.
Bennet J.V., Brodie J.L., Benner E.J. and Kirby W.M.M. (1966): Appl. Microbiol. Simplified accurate method for antibiotic assay on clinical specimens,14, 170–177.
Wagner J.G. (1967): Clin. Pharmacol. Ther., Use of computers in pharmacokinetics,8, 201–218.
Jaffe J.M., Poust R.I., Felds S.L. and Colaizzi J.L. (1974): J. Pharm. Sci., Influence of repetitive dosing and altered urinary pH on doxycycline excretion in humans,63, 8, 1256–1260.
Mahon W.A., Johnson G.E., Endrenyl L., Kelly M.F. and Fenton S.S.A. (1976): Scand. J. Infect. Dis., The elimination of tritiated doxycycline in normal subjects and in patients with severely impaired renal function,9, 24–31.
Modr Z., Dvorzhachek K., Shmidt O. and Nechaskova A. (1974): Antibiotiki, Pharmacokinetics of doxycycline on its repeated oral administration,19, 12, 1063–1067.
Fabre J., Pitton J.S., Virieux C, Daurencet F.L., Bernhardt J.P. and Godel J.C. (1967): Schweiz. med. Wschr., La doxycycline: absorption, distribution et excrétion d’un nouvel antibiotique à large spectre chez l’homme,97, 28, 915–924.
Von Wittenau M.S. and Twomey T.M. (1971): Chemotherapy, The disposition of doxycycline by man and dog,16, 217–228.
Tillement J.P. et Chauvelot L. (1978): Thérapie, Antibiotiques et fixation protéique,33, 3, 235–249.
Fourtillan J.B. et Saux M.Cl. (1978): Sem. Hop. PARIS, Intérêt des tétracyclines de deuxième génération. Comportement pharmacocinétique,54, 4, 224–230.
Green R.G., Brown J.R. and Calvert R.T. (1976): J. Pharm. Pharmac, Estimation of the degree of binding of tetracyclines in human plasma,28, 514–515.
Kunin C.M., Craig W.A., Kornguth M. and Monson R. (1973): Ann. N.Y. Acad. Sci., Influence of binding on the pharmacologic activity of antibiotics,226, 214–224.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Michel, G., Mosser, J. & Fauran, F. Serum kinetics of doxycycline polyphosphate in dogs. European Journal of Drug Metabolism and Pharmacokinetics 4, 43–48 (1979). https://doi.org/10.1007/BF03189398
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF03189398